loxoprofen (Guangzhou Aobo Pharmaceutical Technology/Guangdong Lewwin Pharmaceutical Research Institute)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameloxoprofen (Guangzhou Aobo Pharmaceutical Technology/Guangdong Lewwin Pharmaceutical Research Institute)
Drug Alias Nameloxoprofen
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid receptor antagonistsCyclooxygenases inhibitors
TargetsProstanoid receptorCyclooxygenases
Therapy Area/IndicationsOcular inflammationEye Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Aobo Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Aobo Pharmaceutical Technology Co LtdGuangdong Lewwin Pharmaceutical Research Institute Co Ltd
Inactive CompaniesN/A
Active IndicationsOcular inflammationEye Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A